olfactory receptor family 7 subfamily A member 17Genealiases: BC85395_4 · HTPCRX19
Q-omics provides the consensus-scored OR7A17 profile across patient tissues and cancer cell-line models. OR7A17 expression is associated with patient survival in 16 of 34 cancer types, with the highest sampling consensus in PAAD. Additionally, OR7A17 RNA expression shows 6,166 significant pathway-activity associations, with the highest sampling consensus in STAD. Together, these results highlight PAAD, and STAD as cancer lineages where OR7A17 shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.
Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.
Premium analyses for OR7A17 — synthetic lethality, tumor antigen, and pembrolizumab response.
This table summarizes OR7A17 survival associations across molecular data types. OR7A17 RNA expression shows survival associations in the most cancer types (16), followed by mutation status (7). The rightmost column indicates the cancer type with the highest sampling consensus for each molecular layer.
This table ranks reproducible OR7A17 RNA expression–survival associations across cancer types. High OR7A17 expression shows unfavorable associations in PAAD, LUAD, OV, STAD, KIRC and KIRP. The PAAD Kaplan–Meier curve shows clear separation, with the high-expression group declining faster, consistent with the unfavorable association (log-rank p < 0.001). Together, the overview and detailed table identify PAAD as the clearest survival context for OR7A17 RNA expression.
This table shows molecular features associated with OR7A17 in patient tissues and cancer cell lines. In patient samples, OR7A17 shows the broadest associations at the RNA and protein expression levels, with STAD recurring as the lineage with the largest associated feature set. In cancer cell lines, OR7A17 RNA and mutation anchors are most strongly linked to RNA-expression features, especially in UPPER_AERODIGESTIVE_TRACT, while CRISPR and shRNA rows add functional-dependency signals in LUNG_NSCLC_LUAD and SKIN.
